Identification of novel GH-regulated genes in C2C12 cells

Hormone and Metabolic Research

Volumn 43, Issue 13, 2011, Pages 919-930

  Resmini, E ^a   Morte, B ^b   Sorianello, E ^c   Gallardo, E ^a   De Luna, N ^a   Illa, I ^a   Zorzano, A ^c   Bernal, J ^b   Webb, S M ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

Author keywords

cell cultures; growth hormone; microarrays; skeletal muscle

Indexed keywords

GROWTH HORMONE;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DOWN REGULATION; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; IN VITRO STUDY; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; SKELETAL MUSCLE; UPREGULATION;

ANIMALS; CELL LINE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN GROWTH HORMONE; HUMANS; MICE; MUSCLE FIBERS, SKELETAL; PROTEINS;

MURINAE;

EID: 83155173961     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0031-1291285     Document Type: Article

References (57)

1. Isaksson O G, Eden S, Jansson J O. Mode of action of pituitary growth hormone on target cells. Annu Rev Physiol: 1985; 47 483 489
2. Cesea T I, Cui T X, Piwien-Pilipuk G, Kaplani J, Calinescu A A, Huo J S, Iiguez-Lluh J A, Kwok R, Schwartz J. Multiple mechanisms of growth hormone-regulated gene transcription. Mol Genet Metab: 2007; 90 126 133 (Pubitemid 46108616)
3. Piwien-Pilipuk G, Huo J S, Schwartz J. Growth hormone signal transduction. J Pediatr Endocrinol Metab: 2002; 1 771 786 (Pubitemid 34704828)
4. Mathews L, Enberg B, Norstedt G. Regulation of rat growth hormone receptor gene expression. J Biol Chem: 1989; 264 9905 9910 (Pubitemid 19159257)
5. Isaksson O G, Jansson J O, Gause I A. Growth hormone stimulates longitudinal bone growth directly. Science: 1982; 216 1237 1239 (Pubitemid 12080057)
6. Alexopoulou O, Abs R, Maiter D. Treatment of adult growth hormone deficiency: who, why and how? A review. Acta Clin Belg: 2010; 65 1322
7. Isaksson O G, Lindahl A, Nilsson A, Isgaard J. Mechanism of the stimulatory effect of growth hormone on longitudinal bone growth. Endocr Rev: 1987; 8 426 438
8. Clemmons D R. The diagnosis and treatment of growth hormone deficiency in adults. Curr Opin Endocrinol Diabetes Obes: 2010; 17 377 383
9. Attanasio A F, Bates P C, Ho K K, Webb S M, Ross R J, Strasburger C J, Bouillon R, Crowe B, Selander K, Valle D, Lamberts S W. Hypopituitary Control and Complications Study International Advisory Board. Human growth hormone replacement in adult hypopituitary patients: long-term effects on body composition and lipid status 3-year results from the HypoCCS Database. J Clin Endocrinol Metab: 2002; 87 1600 1606 (Pubitemid 34618501)
10. Davidson M B. Effect of growth hormone on carbohydrate and lipid metabolism. Endocr Rev: 1987; 8 115 131
11. Fryburg D A, Barrett E J. The regulation of amino acid and protein metabolism by growth hormone. In: Kostyo J L. (ed.) Hormonal Control of Growth. NY American Physiological Soc: 1999; 515 536
12. Webb S M. Measurements of quality of life in patients with growth hormone deficiency. J Endocrinol Invest: 2008; 31 52 55
13. Huo J S, McEachin R C, Cui T X, Duggal N K, Hai T, States D J, Schwartz J. Profiles of growth hormone (GH)-regulated genes reveal time-dependent responses and identify a mechanism for regulation of activating transcription factor 3 by GH. J Biol Chem: 2006; 28 4132 4141 (Pubitemid 43847840)
14. Yoon J B, Berry S A, Seelig S, Towle H C. An inducible nuclear factor binds to a growth hormone-regulated gene. J Biol Chem: 1990; 265 19947 19954 (Pubitemid 120013955)
15. Le Cam A, Pantescu V, Paquereau L, Legraverend C, Fauconnier G, Asins G. cis-Acting elements controlling transcription from rat serine protease inhibitor 2.1 gene promoter. Characterization of two growth hormone response sites and a dominant purine-rich element. J Biol Chem: 1994; 269 21532 21539
16. Paul C, Seiliez I, Thissen J P, Le Cam A. Regulation of expression of the rat SOCS-3 gene in hepatocytes by growth hormone, interleukin-6 and glucocorticoids mRNA analysis and promoter characterization. Eur J Biochem: 2000; 267 5849 5857
17. Vidal O M, Merino R, Rico-Bautista E, Fernandez-Perez L, Chia D J, Woelfle J, Ono M, Lenhard B, Norstedt G, Rotwein P, Flores-Morales A. In vivo transcript profiling and phylogenetic analysis identifies suppressor of cytokine signaling 2 as a direct signal transducer and activator of transcription 5b target in liver. Mol Endocrinol: 2007; 21 293 311 (Pubitemid 46041708)
18. Tollet-Egnell P, Flores-Morales A, Stavrus-Evers A, Sahlin L, Norstedt G. Growth hormone regulation of SOCS-2, SOCS-3, and CIS messenger ribonucleic acid expression in the rat. Endocrinology: 1999; 140 3693 3704 (Pubitemid 30645425)
19. Flores-Morales A, Stahlberg N, Tollet-Egnell P, Lundeberg J, Malek R L, Quackenbush J, Lee N H, Norstedt G. Microarray analysis of the in vivo effects of hypophysectomy and growth hormone treatment on gene expression in the rat. Endocrinology: 2001; 142 3163 3176 (Pubitemid 32577105)
20. Gil H, Lozano J J, Alvarez-Garca O, Secades-Vzquez P, Rodrguez-Surez J, Garca-Lpez E, Carbajo-Prez E, Santos F. Differential gene expression induced by growth hormone treatment in the uremic rat growth plate. Growth Horm IGF Res: 2008; 18 353 359 (Pubitemid 351729194)
21. Chia D J, Rotwein P. Defining the epigenetic actions of growth hormone: acute chromatin changes accompany GH-activated gene transcription. Mol Endocrinol: 2010; 24 2038 2049
22. Chen Y, Lin G, Huo J S, Barney D, Wang Z, Livshiz T, States D J, Qin Z S, Schwartz J. Computational and functional analysis of growth hormone (GH)-regulated genes identifies the transcriptional repressor Bβ-cell lymphoma 6 (Bc16) as a participant in GH-regulated transcription. Endocrinology: 2009; 150 3645 3654
23. Chow J C, Ling P R, Qu Z, Laviola L, Ciccarone A, Bistrian B R, Smith R J. Growth hormone stimulates tyrosine phosphorylation of JAK2 and STAT5, but not insulin receptor substrate-1 or SHC proteins in liver and skeletal muscle of normal rats in vivo. Endocrinology: 1996; 137 2880 2886 (Pubitemid 26192182)
24. Halevy O, Hodik V, Mett A. The effects of growth hormone on avian skeletal muscle satellite cell proliferation and differentiation. Gen Comp Endocrinol: 1996; 101 43 52 (Pubitemid 26108495)
25. Adamafio N A, Towns R J, Kostyo J L. Growth hormone receptors and action in BC3H-1 myocytes. Growth Regul: 1991; 1 17 22
26. Webb S M, de Andrs-Aguayo I, Rojas-Garca R, Ortega E, Gallardo E, Mestrn A, Serrano-Munuera C, Casamitjana R, Illa I. Neuromuscular dysfunction in adult growth hormone deficiency. Clin Endocrinol (Oxf): 2003; 59 450 458 (Pubitemid 37188175)
27. Sadowski C L, Wheeler T T, Wang L H, Sadowski H B. GH regulation of IGF-I and suppressor of cytokine signaling gene expression in C2C12 skeletal muscle cells. Endocrinology: 2001; 142 3890 3900 (Pubitemid 32802661)
28. Segard H B, Moulin S, Boumard S, Augier de Crmiers C, Kelly P A, Finidori J. Autocrine growth hormone production prevents apoptosis and inhibits differentiation in C2C12 myoblasts. Cell Signal: 2003; 15 615 623 (Pubitemid 36385167)
29. Gentleman R C, Carey V J, Bates D M, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, Hornik K, Hothorn T, Huber W, Iacus S, Irizarry R, Leisch F, Li C, Maechler M, Rossini A J, Sawitzki G, Smith C, Smyth G, Tierney L, Yang J Y, Zhang J. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol: 2004; 5 R80
30. Irizarry R A, Hobbs B, Collin F, Beazer-Barclay Y D, Antonellis K J, Scherf U, Speed T P. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics: 2003; 4 249 264
31. Cartharius K, Frech K, Grote K, Klocke B, Haltmeier M, Klingenhoff A, Frisch M, Bayerlein M, Werner T. MathInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics: 2005; 21 2933 2942 (Pubitemid 40916416)
32. Sadowski C L, Wheeler T T, Wang L H, Sadowski H B. GH regulation of IGF-I and suppressor of cytokine signaling gene expression in C2C12 skeletal muscle cells. Endocrinology: 2001; 142 3890 3900 (Pubitemid 32802661)
33. Frost R A, Nystrom G J, Lang C H. Regulation of IGF-I mRNA and signal transducers and activators of transcription-3 and -5 (Stat-3 and -5) by GH in C2C12 myoblasts. Endocrinology: 2002; 143 492 503 (Pubitemid 34107202)
34. Haase H R, Ivanovski S, Waters M J, Bartold P M. Growth hormone regulates osteogenic marker mRNA expression in human periodontal fibroblasts and alveolar bone-derived cells. J Periodontal Res: 2003; 38 366 374 (Pubitemid 37465542)
35. von Bubnoff A, Cho K W. Intracellular BMP signaling regulation in vertebrates: pathway or network? Dev Biol: 2001; 239 1 14 (Pubitemid 33052049)
36. Ouyang X, Fujimoto M, Nakagawa R, Serada S, Tanaka T, Nomura S, Kawase I, Kishimoto T, Naka T. SOCS-2 interferes with myotube formation and potentiates osteoblast differentiation through upregulation of JunB in C2C12 cells. J Cell Physiol: 2006; 207 428 436
37. Kostenuik P J, Shalhoub V. Osteoprotegerin: a physiological and pharmacological inhibitor of bone resorption. Curr Pharm Des: 2001; 7 613 635 (Pubitemid 32427765)
38. Mrak E, Villa I, Lanzi R, Losa M, Guidobono F, Rubinacci A. Growth hormone stimulates osteoprotegerin expression and secretion in human osteoblast-like cells. J Endocrinol: 2007; 192 639 645 (Pubitemid 46455966)
39. Lanzi R, Losa M, Villa I, Gatti E, Sirtori M, Dal Fiume C, Rubinacci A. GH replacement therapy increases plasma osteoprotegerin levels in GH-deficient adults. Eur J Endocrinol: 2003; 148 185 191 (Pubitemid 36312939)
40. Reinhard H, Lajer M, Gall M A, Tarnow L, Parving H H, Rasmussen L M, Rossing P. Osteoprotegerin and mortality in type 2 diabetic patients. Diabetes Care: 2010; 33 2561 2566
41. Corallini F, Gonelli A, DAurizio F, di Iasio M G, Vaccarezza M. Mesenchymal stem cells-derived vascular smooth muscle cells release abundant levels of osteoprotegerin. Eur J Histochem: 2009; 53 19 24
42. Morena M, Dupuy A M, Jaussent I, Vernhet H, Gahide G, Klouche K, Bargnoux A S, Delcourt C, Canaud B, Cristol J P. A cut-off value of plasma osteoprotegerin level may predict the presence of coronary artery calcifications in chronic kidney disease patients. Nephrol Dial Transplant: 2009; 24 3389 3397
43. Heximer S P, Knutsen R H, Sun X, Kaltenbronn K M, Rhee M H, Peng N, Oliveira-dos-Santos A, Penninger J M, Muslin A J, Steinberg T H, Wyss J M, Mecham R P, Blumer K J. Hypertension and prolonged vasoconstrictor signaling in RGS2-deficient mice. J Clin Invest: 2003; 111 445 452 (Pubitemid 36228001)
44. Tang K M, Wang G R, Lu P, Karas R H, Aronovitz M, Heximer S P, Kaltenbronn K M, Blumer K J, Siderovski D P, Zhu Y, Mendelsohn M E. Regulator of G-protein signaling-2 mediates vascular smooth muscle relaxation and blood pressure. Nat Med: 2003; 9 1506 1512 (Pubitemid 38004778)
45. Takimoto E, Koitabashi N, Hsu S, Ketner E A, Zhang M, Nagayama T, Bedja D, Gabrielson K L, Blanton R, Siderovski D P, Mendelsohn M E, Kass D A. Regulator of G protein signaling 2 mediates cardiac compensation to pressure overload and antihypertrophic effects of PDE5 inhibition in mice. J Clin Invest: 2009; 119 408 420
46. Zhang W, Anger T, Su J, Hao J, Xu X, Zhu M, Gach A, Cui L, Liao R, Mende U. Selective Loss of Fine Tuning of Gq/11 Signaling by RGS2 Protein Exacerbates Cardiomyocyte Hypertrophy. J Biol Chem: 2006; 281 5811 5820 (Pubitemid 43853012)
47. Hurst J H, Mendpara N, Hooks SB. Regulator of G-protein signalling expression and function in ovarian cancer cell lines. Cell Mol Biol Lett: 2009; 14 153 174
48. Smalley M J, Iravani M, Leao M, Grigoriadis A, Kendrick H, Dexter T, Fenwick K, Regan J L, Britt K, McDonald S, Lord C J, Mackay A, Ashworth A. Regulator of G-protein signalling 2 mRNA is differentially expressed in mammary epithelial subpopulations and over-expressed in the majority of breast cancers. Breast Cancer Res: 2007; 9 R85
49. Wang J, Lippman S M, Lee J J, Yang H, Khuri F R, Kim E, Lin J, Chang D W, Lotan R, Hong W K, Wu X. Genetic variations in regulator of G-protein signaling genes as susceptibility loci for second primary tumor/recurrence in head and neck squamous cell carcinoma. Carcinogenesis: 2010; 31 1755 1761
50. Jiang Z, Wang Z, Xu Y, Wang B, Huang W, Cai S. Analysis of RGS2 expression and prognostic significance in stage II and III colorectal cancer. Biosci Rep: 2010; 30 383 390
51. Orme S M, McNally R J, Cartwright R A, Belchetz P E. Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group. J Clin Endocrinol Metab: 1998; 83 2730 2734 (Pubitemid 28493768)
52. Herzog H, Hort Y J, Ball H J, Hayes G, Shine J, Selbie L A. Cloned human neuropeptide Y receptor couples to two different second messenger systems. Proc Natl Acad Sci USA: 1992; 89 5794 5798
53. Hodges G J, Jackson D N, Mattar L, Johnson J M, Shoemaker J K. Neuropeptide Y and neurovascular control in skeletal muscle and skin. Am J Physiol Regul Integr Comp Physiol: 2009; 297 546 555
54. Baldock P A, Allison S J, Lundberg P, Lee N J, Slack K, Lin E J, Enriquez R F, McDonald M M, Zhang L, During M J, Little D G, Eisman J A, Gardiner E M, Yulyaningsih E, Lin S, Sainsbury A, Herzog H. Novel role of Y1 receptors in the coordinated regulation of bone and energy homeostasis. J Biol Chem: 2007; 282 19092 19102 (Pubitemid 47100174)
55. Michel M C, Beck-Sickinger A, Cox H, Doods H N, Herzog H, Larhammar D, Quirion R, Schwartz T, Westfall T. XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacological Rev: 1998; 50 143 150 (Pubitemid 28158845)
56. Franquinho F, Liz M A, Nunes A F, Neto E, Lamghari M, Sousa M M. Neuropeptide Y and osteoblast differentiation the balance between the neuro-osteogenic network and local control. FEBS J: 2010; 277 3664 3674
57. Teixeira L, Sousa D M, Nunes A F, Sousa M M, Herzog H, Lamghari M. NPY revealed as a critical modulator of osteoblast function in vitro: new insights into the role of Y1 and Y2 receptors. J Cell Biochem: 2009; 107 908 916